MwanzoNATCOPHARM • NSE
add
Natco Pharma Ltd
Bei iliyotangulia
₹ 1,000.80
Bei za siku
₹ 1,000.00 - ₹ 1,024.90
Bei za mwaka
₹ 726.80 - ₹ 1,059.00
Thamani ya kampuni katika soko
182.65B INR
Wastani wa hisa zilizouzwa
2.12M
Uwiano wa bei na mapato
11.73
Mgao wa faida
0.49%
Ubadilishanaji wa msingi
NSE
Habari za soko
Yahoo Finance
saa 7 zilizopita
Is Now The Moment To Reassess Dow (DOW) After Its Recent 7% Weekly Jump
0.95%
1.33%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 6.47B | 36.33% |
Matumizi ya uendeshaji wa biashara | 4.02B | 0.37% |
Mapato halisi | 1.52B | 13.91% |
Kiwango cha faida halisi | 23.40 | -16.46% |
Mapato kwa kila hisa | 8.46 | 13.86% |
EBITDA | 1.57B | 326.63% |
Asilimia ya kodi ya mapato | 12.03% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 32.04B | 30.08% |
Jumla ya mali | — | — |
Jumla ya dhima | — | — |
Jumla ya hisa | 86.54B | — |
hisa zilizosalia | 179.08M | — |
Uwiano wa bei na thamani | 2.07 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 3.15% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 1.52B | 13.91% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1981
Makao Makuu
Tovuti
Wafanyakazi
4,199
